5661 DAN (Sulindac 150 mg)
Pill imprint 5661 DAN has been identified as Sulindac 150 mg.
Sulindac is used in the treatment of pain; rheumatoid arthritis; osteoarthritis; ankylosing spondylitis; gout, acute (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy. Sulindac 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 5661 DAN (Sulindac 150 mg)
- 150 mg
- 10.00 mm
- Prescription only
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- magnesium stearate
|NDC Code||Manufacturer / Repackager|
|66267-0264||Nucare Pharmaceuticals Inc (repackager)|
|54868-0879||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
Sulindac is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...